| Variable | Categories | Frequency (N) | Percentage (%) |
| Number of respondents who had been vaccinated against COVID-19 | Yes | 124 | 41.1% |
| No | 178 | 58.9% | |
| Number of doses of COVID-19 vaccine received by those vaccinated | One dose | 35 | 28.23% |
| Two doses | 75 | 60.48% | |
| More than two doses | 14 | 11.29% | |
| Total | 124 | 100 | |
| Type of COVID-19 vaccine received | AstraZeneca | 27 | 21.77% |
| Johnson & Johnson | 49 | 39.52% | |
| Pfizer | 16 | 12.90% | |
| Moderna | 11 | 8.87% | |
| AstraZeneca + Moderna | 3 | 2.42% | |
| Johnson & Johnson + Moderna | 2 | 1.61% | |
| Johnson & Johnson + Pfizer | 3 | 2.42% | |
| Moderna + AstraZeneca | 1 | 0.81% | |
| Moderna+ Pfizer | 3 | 2.42% | |
| Pfizer + AstraZeneca | 1 | 0.81% | |
| Pfizer + Johnson & Johnson | 5 | 4.03% | |
| Pfizer + Moderna | 3 | 2.42% | |
| Total | 124 | 100 | |
| Places from where the respondents received the vaccine | Private health facility | 14 | 11.3% |
| Public health facility | 101 | 81.5% | |
| Others | 9 | 7.3% | |
| Total | 124 | 100 | |
| The proportion of respondents that experienced side effects. | Yes | 94 | 75.8% |
| No | 30 | 24.2% | |
| Total | 124 | 100 | |
| Headache | 18 | 19.1% | |
| Joint pain | 5 | 5.3% | |
| Generalized pain | 4 | 4.3% | |
| Abscess at the injection site | 3 | 3.2% | |
| Local reaction | 2 | 2.1% | |
| Other | 1 | 1.1% | |
| Skin rash | 1 | 1.1% | |
| Vomiting | 1 | 1.1% | |
| Total | 94 | 100 |